These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21272663)

  • 1. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
    Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
    Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy.
    Wu J; Wang Y; Wang Y; Zhao M; Zhang X; Gui L; Zhao S; Zhu H; Zhao J; Peng S
    Int J Nanomedicine; 2015; 10():2925-38. PubMed ID: 25931819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu.
    Chen Y; Cui G; Zhao M; Wang C; Qian K; Morris-Natschke S; Lee KH; Peng S
    Bioorg Med Chem; 2008 Jun; 16(11):5914-25. PubMed ID: 18495483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.
    Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T
    Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-dependent vasorelaxant and anti-aggregatory effect and mechanism of action of some antifibrinogen RGD (Arg-Gly-Asp-containing) peptides.
    Torday LL; Pataricza J; Balogh GE; Zarándi M; Penke B; Papp JG
    J Pharm Pharmacol; 1998 Jun; 50(6):667-71. PubMed ID: 9680079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
    Mel'nik OV; Martinovich VP; Golubovich VP
    Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
    Sofuku S; Hoshida A; Shimada T; Takada Y; Takakuwa T
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1799-801. PubMed ID: 10748723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
    Imura Y; Stassen JM; Bunting S; Stockmans F; Collen D
    Blood; 1992 Sep; 80(5):1247-53. PubMed ID: 1515641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.
    Jin S; Wang Y; Zhu H; Wang Y; Zhao S; Zhao M; Liu J; Wu J; Gao W; Peng S
    ACS Nano; 2013 Sep; 7(9):7664-73. PubMed ID: 23931063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
    J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.
    Wu J; Zhu H; Yang G; He J; Wang Y; Zhao S; Zhang X; Gui L; Zhao M; Peng S
    Int J Nanomedicine; 2018; 13():1139-1158. PubMed ID: 29520141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis.
    Udvardy M; Schwartzott D; Jackson K; McKee PA
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):11-6. PubMed ID: 7795148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-metastatic and anti-invasive effects of polymeric Arg-Gly-Asp (RGD) peptide, poly(RGD), and its analogues.
    Saiki I; Murata J; Matsuno K; Ogawa R; Nishi N; Tokura S; Azuma I
    Jpn J Cancer Res; 1990; 81(6-7):660-7. PubMed ID: 2119367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of complexation of Cu(II) with P6A peptide and its analogs on their thrombolytic activities.
    Yang M; Cui G; Zhao M; Wang C; Wang L; Liu H; Peng S
    Int J Pharm; 2008 Oct; 362(1-2):81-7. PubMed ID: 18625295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
    Udrardy M; Schwartzott D; Jackson K; McKee PA
    Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity.
    Ozeki E; Matsuda T
    ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation.
    Polverino de Laureto P; Scaramella E; De Filippis V; Marin O; Doni MG; Fontana A
    Protein Sci; 1998 Feb; 7(2):433-44. PubMed ID: 9521121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and cardioprotective effect of a new class of dual-acting agents: phenolic tetrahydro-beta-carboline RGD peptidomimetic conjugates.
    Bi W; Cai J; Liu S; Baudy-Floc'h M; Bi L
    Bioorg Med Chem; 2007 Nov; 15(22):6909-19. PubMed ID: 17827017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.